Dr Yonas Tegegn Woldemariam, WHO Representative to Uganda, welcomed the country's progress in key healthcare areas.
In this explainer, we lay out why the disease, which can kill up to 50 percent of patients who progress to severe symptoms, ...
The ‘cousin’ of Ebola that leaves its victims in a ‘ghost-like’ state is one of the world’s deadliest viruses – and there’s ...
In some pet-owning homes in Portugal and the UK, sick pets and their owners were colonized by similar strains of resistant ...
S ubjects at HJF Medical Research International in Nigeriahave received a Lassa fever virus (LASV) vaccine candidate in the ...
The death toll from the Ebola outbreak in West Africa's three hardest-hit countries, Guinea, Liberia and Sierra Leone, has ...
Did you know that life expectancy — for both men and women — has shot up by 23 years since 1950, extending billions of people ...
NEW YORK, NY / ACCESSWIRE / April 4, 2024 / Participants at HJF Medical Research International in Abuja, Nigeria, have been ...
Soligenix’s SuVax gets US FDA orphan drug designation for prevention and post-exposure prophylaxis against SUDV infection." Princeton, New Jersey Saturday, April 13, 2024, 09:00 Hrs [IST] ...
Global deployment of rapid diagnostic tests to boost fight against cholera: Geneva Saturday, April 6, 2024, 12:00 Hrs [IST] More than 1.2 million cholera rapid diagnostic tests wi ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidate · Participants in Nigeria have been vaccinated with a Lassa fever ...